We propose to establish the Center for Hemoglobin Research in Minorities (CHaRM), which will build on and synergize with the existing HBCU Research Scientist Program. The CHaRM's ultimate goal is to provide and to improve the necessary research infrastructure, while augmenting science education and research training for pre- and postdoctoral students, and strengthening scientific faculty research and career development. We will establish a NHLBI Research Center at Howard University that will augment and strengthen research capabilities and resources in biomedical and behavioral research related to heart, lung and blood diseases and disorders in minority populations. This proposal will build on previously developed Research Scientist Program at Howard University's Center for Sickle Cell Disease (CSCD) that was supported by NHLBI from 1999 to 2012 and recently received the P30 award for Phase I of this program.
In Aim 1, we will establish a center of excellence for the study of hemoglobinopathies, iron metabolism, and oxygen sensing. We will recruit an external mid-level or senior investigator who will serve as program director and retain the existing recently hired junior faculty. We will also establish a steering committee, an external advisory board and use an external evaluator for the program.
In Aim 2, we will establish an administrative core to provide support and conduct training activities.
In Aim 3, we will educate and train minority students and fellows by providing research and laboratory experience, developing additional scientific curricula, facilitate scientific exchange and conduct seminars.
In Aim 4, we will expand and enhance the research advances made by the Howard University Research Scientist Program in clinical and molecular aspects of sickle cell disease, iron metabolism, and oxygen sensing.
In Aim 5, we will enhance and facilitate existing collaborations within and outside of Howard University and share existing resources. The underlying themes of the research we envision are to reduce health disparities and to enhance excellence in research into heart, lung and blood diseases at Howard University. In pursuit of the scientific and educational goals, an integral part of the program will be to obtain additional research support from NIH and other sources.
The mission of the CHaRM is relevant to public Health because it is aimed at reducing health disparities and enhancing excellence into heart, lung and blood diseases at Howard University. The proposed activities are relevant to the NIH mission that pertains to reduce vulnerability of the population to chronic and infectious diseases and to train and educate minority students and medical fellows.
|Mehari, Alem; Thomas, Alvin V; Thomas, Alicia N et al. (2016) Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension. Ethn Dis 26:545-552|
|Yeruva, Sri L H; Paul, Yonette; Oneal, Patricia et al. (2016) Renal Failure in Sickle Cell Disease: Prevalence, Predictors of Disease, Mortality and Effect on Length of Hospital Stay. Hemoglobin 40:295-299|
|Baer, Alan; Shafagati, Nazly; Benedict, Ashwini et al. (2016) Protein Phosphatase-1 regulates Rift Valley fever virus replication. Antiviral Res 127:79-89|
|Drawz, Paul; Ayyappan, Sabarish; Nouraie, Mehdi et al. (2016) Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC. Clin J Am Soc Nephrol 11:207-15|
|Whitesell, P L; Owoyemi, O; Oneal, P et al. (2016) Sleep-disordered breathing and nocturnal hypoxemia in young adults with sickle cell disease. Sleep Med 22:47-9|
|Ogunwuyi, Oluwaseun; Kumari, Namita; Smith, Kahli A et al. (2016) Antiretroviral Drugs-Loaded Nanoparticles Fabricated by Dispersion Polymerization with Potential for HIV/AIDS Treatment. Infect Dis (Auckl) 9:21-32|
|Boosalis, Michael S; Sangerman, Jose I; White, Gary L et al. (2015) Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice. PLoS One 10:e0144660|
|Kassim, Olakunle O; Copeland, Robert L; Kenguele, Hilaire M et al. (2015) Antiproliferative activities of Fagara xanthoxyloides and Pseudocedrela kotschyi against prostate cancer cell lines. Anticancer Res 35:1453-8|
|van Beers, Eduard J; Yang, Yanqin; Raghavachari, Nalini et al. (2015) Iron, inflammation, and early death in adults with sickle cell disease. Circ Res 116:298-306|
|Kumari, Namita; Kulkarni, Amol A; Lin, Xionghao et al. (2015) Inhibition of HIV-1 by curcumin A, a novel curcumin analog. Drug Des Devel Ther 9:5051-60|
Showing the most recent 10 out of 31 publications